Are you ready to participate in new research?  Leaders in autoimmunology are currently researching a drug for patients with multiple sclerosis like you. Your assistance is needed to help complete the ACCLAIM Study.

PatientsLikeMe, in collaboration with the Immune Tolerance Network, wants to partner with you in a Phase II clinical trial of abatacept. You may know this treatment by its branded name, Orencia. It is already used (with FDA approval) to treat rheumatoid arthritis, another autoimmune disease. It has also been studied in conditions like psoriasis and to prevent transplant rejection. Thousands of people have received abatacept for one condition or another, so doctors already know a lot about it. Because it has not been thoroughly tested in MS, however, it is considered an experimental therapy for patients like you.

About Participating

Here are a few things you should know about participating in the ACCLAIM Study:

• Participants receive frequent neurological and MRI tests to monitor their progress
• Study participants meet regularly with physician experts
• All participants who remain eligible throughout the study will receive two courses of treatment, one with the study drug abatacept and a second with a placebo (one in three participants will receive the placebo in the first course)
• All study-related care and treatments are provided at no cost to you
• Participation lasts up to 15 months

Do You Qualify?

 

To participate in the study, you must:

• Be between the ages of 18-65
• Have been diagnosed with relapsing-remitting MS
• Have had one or more relapses, or new MRI lesions in the past year

 How to Learn More

To find out if you qualify for the study, visit www.acclaimstudy.org today to answer the pre-screening questions. Consider participating in ACCLAIM today!